Phase 2a is the disclaimer. Investors know the purpose of Phase 2a/b is to determine the efficacy with a smaller sample size and the purpose of Phase 3 is to confirm the efficacy with a larger sample size. The graph clearly states the Phase 2a data “provided basis to proceed to next study”.